Literature DB >> 14744212

Hypocretin (orexin): role in normal behavior and neuropathology.

Jerome M Siegel1.   

Abstract

The hypocretins (Hcrts, also known as orexins) are two peptides, both synthesized by a small group of neurons, most of which are in the lateral hypothalamic and perifornical regions of the hypothalamus. The hypothalamic Hcrt system directly and strongly innervates and potently excites noradrenergic, dopaminergic, serotonergic, histaminergic, and cholinergic neurons. Hcrt also has a major role in modulating the release of glutamate and other amino acid transmitters. Behavioral investigations have revealed that Hcrt is released at high levels in active waking and rapid eye movement (REM) sleep and at minimal levels in non-REM sleep. Hcrt release in waking is increased markedly during periods of increased motor activity relative to levels in quiet, alert waking. Evidence for a role for Hcrt in food intake regulation is inconsistent. I hypothesize that Hcrt's major role is to facilitate motor activity tonically and phasically in association with motivated behaviors and to coordinate this facilitation with the activation of attentional and sensory systems. Degeneration of Hcrt neurons or genetic mutations that prevent the normal synthesis of Hcrt or of its receptors causes human and animal narcolepsy. Narcolepsy is characterized by an impaired ability to maintain alertness for long periods and by sudden losses of muscle tone (cataplexy). Administration of Hcrt can reverse symptoms of narcolepsy in animals, may be effective in treating human narcolepsy, and may affect a broad range of motivated behaviors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744212      PMCID: PMC8765219          DOI: 10.1146/annurev.psych.55.090902.141545

Source DB:  PubMed          Journal:  Annu Rev Psychol        ISSN: 0066-4308            Impact factor:   24.137


  95 in total

1.  Prominent expression of Narp in central vestibular pathways: selective effect of labyrinth ablation.

Authors:  Irving M Reti; Lloyd B Minor; Jay M Baraban
Journal:  Eur J Neurosci       Date:  2002-11       Impact factor: 3.386

2.  Distribution of orexin receptor mRNA in the rat brain.

Authors:  P Trivedi; H Yu; D J MacNeil; L H Van der Ploeg; X M Guan
Journal:  FEBS Lett       Date:  1998-10-30       Impact factor: 4.124

3.  Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system.

Authors:  T L Horvath; C Peyron; S Diano; A Ivanov; G Aston-Jones; T S Kilduff; A N van Den Pol
Journal:  J Comp Neurol       Date:  1999-12-13       Impact factor: 3.215

Review 4.  Diagnostic aspects of narcolepsy.

Authors:  M S Aldrich
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

5.  Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.

Authors:  R M Chemelli; J T Willie; C M Sinton; J K Elmquist; T Scammell; C Lee; J A Richardson; S C Williams; Y Xiong; Y Kisanuki; T E Fitch; M Nakazato; R E Hammer; C B Saper; M Yanagisawa
Journal:  Cell       Date:  1999-08-20       Impact factor: 41.582

6.  Changes in inhibitory amino acid release linked to pontine-induced atonia: an in vivo microdialysis study.

Authors:  Tohro Kodama; Yuan-Yang Lai; Jerome M Siegel
Journal:  J Neurosci       Date:  2003-02-15       Impact factor: 6.167

7.  Independent feeding and metabolic actions of orexins in mice.

Authors:  M Lubkin; A Stricker-Krongrad
Journal:  Biochem Biophys Res Commun       Date:  1998-12-18       Impact factor: 3.575

8.  A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats.

Authors:  J S Lin; K Sakai; G Vanni-Mercier; M Jouvet
Journal:  Brain Res       Date:  1989-02-13       Impact factor: 3.252

9.  Neuronal activity in narcolepsy: identification of cataplexy-related cells in the medial medulla.

Authors:  J M Siegel; R Nienhuis; H M Fahringer; R Paul; P Shiromani; W C Dement; E Mignot; C Chiu
Journal:  Science       Date:  1991-05-31       Impact factor: 47.728

10.  GABA release in the dorsal raphe nucleus: role in the control of REM sleep.

Authors:  D Nitz; J Siegel
Journal:  Am J Physiol       Date:  1997-07
View more
  74 in total

Review 1.  Hypothalamic control of sleep in aging.

Authors:  Asya Rolls
Journal:  Neuromolecular Med       Date:  2012-03-09       Impact factor: 3.843

Review 2.  A theory of behaviour on progressive ratio schedules, with applications in behavioural pharmacology.

Authors:  C M Bradshaw; P R Killeen
Journal:  Psychopharmacology (Berl)       Date:  2012-07-03       Impact factor: 4.530

3.  The injection of hypocretin-1 into the nucleus pontis oralis induces either active sleep or wakefulness depending on the behavioral state when it is administered.

Authors:  Mingchu Xi; Michael H Chase
Journal:  Sleep       Date:  2010-09       Impact factor: 5.849

4.  Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats.

Authors:  Yonghui Li; Sa Li; Chuguang Wei; Huiying Wang; Nan Sui; Gilbert J Kirouac
Journal:  Psychopharmacology (Berl)       Date:  2010-07-20       Impact factor: 4.530

5.  Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA.

Authors:  Mark G LeSage; Jennifer L Perry; Catherine M Kotz; David Shelley; William A Corrigall
Journal:  Psychopharmacology (Berl)       Date:  2010-02-24       Impact factor: 4.530

6.  Behavioral correlates of activity in identified hypocretin/orexin neurons.

Authors:  Boris Y Mileykovskiy; Lyudmila I Kiyashchenko; Jerome M Siegel
Journal:  Neuron       Date:  2005-06-02       Impact factor: 17.173

7.  Orexins: looking forward to sleep, back at addiction.

Authors:  Thomas E Scammell; Clifford B Saper
Journal:  Nat Med       Date:  2007-02       Impact factor: 53.440

8.  GABA-mediated control of hypocretin- but not melanin-concentrating hormone-immunoreactive neurones during sleep in rats.

Authors:  Md Noor Alam; Sunil Kumar; Tariq Bashir; Natalia Suntsova; Melvi M Methippara; Ronald Szymusiak; Dennis McGinty
Journal:  J Physiol       Date:  2004-12-21       Impact factor: 5.182

Review 9.  Sex differences in circadian timing systems: implications for disease.

Authors:  Matthew Bailey; Rae Silver
Journal:  Front Neuroendocrinol       Date:  2013-11-25       Impact factor: 8.606

Review 10.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.